Analyst Consensus ?
ConsensusHold13 ratings
Bullish538.5%
Neutral753.8%
Bearish17.7%
FN2 Earnings Intelligence
Viatris Inc. (VTRS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 16, 2026 |
| Argus Research | Buy | Buy | Maintain | Sep 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 19, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 8, 2026 |
| Jefferies | Buy | Buy | Maintain | Mar 7, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Feb 28, 2025 |
| BMO Capital | Market Perform | Outperform | Downgrade | Feb 17, 2023 |
| Goldman Sachs | Neutral | Neutral | Maintain | May 12, 2022 |
| Citigroup | Neutral | Neutral | Maintain | Mar 10, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 1, 2022 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Mar 10, 2021 |
Upside is calculated against the persisted current price $17.37. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Ashwani Verma | $26 | $17.6 | +49.7% | Oct 5, 2026 |
| Oppenheimer | Analyst unavailable | $25 | $17.18 | +43.9% | Sep 23, 2026 |
| Leerink Partners | Analyst unavailable | $20 | $16.61 | +15.1% | Sep 9, 2026 |
| Argus Research | Analyst unavailable | $20 | $16.75 | +15.1% | Sep 8, 2026 |
| Barclays | Glen Santangelo | $22 | $16.5 | +26.7% | May 19, 2026 |
| Truist Financial | Analyst unavailable | $20 | $16.94 | +15.1% | May 8, 2026 |
| UBS | Ashwani Verma | $18 | $14.58 | +3.6% | Feb 9, 2026 |
| Piper Sandler | Analyst unavailable | $12 | $13.12 | -30.9% | Jan 28, 2026 |
| Argus Research | Analyst unavailable | $15 | $12.84 | -13.6% | Jan 16, 2026 |
| Truist Financial | Les Sulewski | $16 | $12.4 | -7.9% | Jan 7, 2026 |
| Truist Financial | Analyst unavailable | $15 | $9.93 | -13.6% | Oct 15, 2025 |
| Jefferies | Glen Santangelo | $15 | $11.77 | -13.6% | Jul 19, 2024 |
| Piper Sandler | David Amsellem | $13 | $11.83 | -25.2% | Mar 28, 2024 |
| Piper Sandler | David Amsellem | $10 | $9.84 | -42.4% | Jun 26, 2023 |
| Barclays | Analyst unavailable | $15 | $12.16 | -13.6% | Feb 1, 2023 |
| UBS | Ashwani Verma | $12 | $10.83 | -30.9% | Nov 9, 2022 |
| UBS | Ashwani Verma | $9 | $10.77 | -48.2% | Jun 13, 2022 |
Track every rating change on VTRS the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.